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To study the association between time of hospitalization and in-hospital mortality for acute 
myocardial infarction (AMI). 
 
Methods and Results 
Patients admitted with ST-elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) 
across 243 hospitals in England and Wales between 1st January 2004 and 31st March 2013 
were included. The outcome measure was in-hospital mortality. Adjusted odds ratios for in-
hospital mortality were estimated across six four-hourly time periods over the 24-hour clock 
using multilevel logistic regression, inverse-probability weighting propensity score and 
instrumental variable analysis. Among 615,035 patients (median age 70.0 years, IQR 59.0 - 
80.0 years; 406,519 (66.0%) men), there were 52,777 (8.8%) in-hospital deaths. At night, 
patients with NSTEMI were more frequently co-morbid, and for STEMI had longer symptom-
onset-to-reperfusion times. For STEMI, unadjusted in-hospital mortality was highest 
between 20:00 and 23:59 (four-hour period range 8.4% to 9.9%; OR compared with 00:00 to 
03:59 reference 1.13, 95% CI 1.07 to 1.20), and for NSTEMI highest between 12:00 to 15:59 
(8.0% to 8.8%; OR compared with 00:00 to 03:59 reference 1.07, 95% CI 1.03 to 1.12). 
However, these differences were only apparent in the earlier years of the study, and were 
attenuated by adjustment for demographics, co-morbidities and clinical presentation. 





There is little evidence to support an association between time of hospitalization and in-
hospital mortality for acute myocardial infarction; variation in in-hospital mortality may be 





Hospital mortality rates for a number of medical conditions may be associated with the time 
of day at which at a patient presents to hospital and, in part, determined by their clinical 
presentation and extent of care received.1-10 For example, thrombolysis times for stroke 
vary diurnally, and this is associated with higher rates of death.10  In patients with acute 
myocardial infarction (AMI), admission to hospital at the weekend is associated with higher 
mortality and lower use of invasive coronary procedures.6,11 Such reports have the potential 
to influence policy and, therefore, change how clinical practice may be provided across all 
medical disciplines.12,13 To our knowledge, however, there are no studies assessing time of 
day effects on in-hospital mortality for patients with AMI.  
 
Notably, there are few data sources which would enable a detailed evaluation of the impact 
of out-of-hour presentation and guideline-indicated therapies on mortality for AMI. The 
Myocardial Ischaemia National Audit Project (MINAP) is a whole country acute coronary 
syndrome registry,14 representing all hospitals in a single health system (the National Health 
Service of England and Wales) with prospective collection of detailed information about 
quality of care and clinical outcomes of patients for over 15 years, and represents an ideal 
conduit to undertake patient- and treatment-specific studies.14-16 Thus, we aimed to use 
data from MINAP to investigate whether time of hospitalization with AMI among 615,035 
patients was associated with in-hospital mortality, and if so, the magnitude of the 






Data and patients 
Participation in MINAP is mandated by the Department of Health for all hospitals in England 
and Wales. Data are collected prospectively at each hospital, electronically encrypted and 
transferred online to a central database. Data entry is subject to routine error checking and 
obligatory annual data validation exercise. Further details of MINAP have been published 
elsewhere.14 The analytical cohort, derived from all patients with AMI admitted to hospital 
between 1st April, 2004 and 31st March, 2013, included 615,035 patients from 243 hospitals 
(supplementary eFigure 1). Patients were eligible for the study if they were aged 18 years or 
over with a diagnosis of ST-elevation myocardial infarction (STEMI) or non-STEMI (NSTEMI). 
The diagnosis was the final diagnosis as determined by local clinicians according to 
presenting history, clinical examination and the results of inpatient investigations in keeping 
with the consensus document of the Joint European Society of Cardiology and American 
College of Cardiology for the diagnoses of AMI.17  
 
Study variables 
We included demographic factors (age, sex, year of hospital admission), past medical history 
(coronary artery bypass grafting (CABG) surgery, percutaneous coronary intervention (PCI), 
chronic heart failure, diabetes mellitus, hypertension, hyperlipidaemia, previous myocardial 
infarction and smoking status), clinical presentation (heart rate, systolic blood pressure, 
troponin concentration, serum creatinine, cardiac arrest, elevated cardiac biomarkers and 
7 
 
ST-segment depression on the ECG), the type of hospital admission (ambulance versus self-
presented to hospital), investigations (ECG, coronary angiography), acute treatments 
(aspirin, thrombolysis or primary PCI for STEMI) and medications already taken or 
prescribed at time of hospitalization (aspirin, angiotensin converting enzyme inhibitors 
(ACEi)/angiotensin-receptor blockers (ARB), é HﾉﾗIﾆWヴゲ, and HMG Co-A reductase inhibitors 
(statins). Time of hospital admission was defined as the time of arrival of the ambulance at 
the hospital, or the accident and emergency department registration time for patients who 
self-presented to the department. It was categorised into six four-hour periods over the 24-
hour clock (00:00 to 03:59; 04:00 to 07:59, 08:00 to 11:59, 12:00 to 15:59, 16:00 to 19:59, 
20:00 to 23:59),10 using 00:00-03:59 as the reference category representing the middle of 
the night. Time of symptom onset was also categorised as for time of hospital admission. 
Night-time was defined as 20:00 to 07:59, and day-time from 08:00 to 19:59. For each 
hospital we calculated its average annual volume and socioeconomic deprivation level 
(mean Townsend score) across all patients recorded in MINAP as attending that hospital 
during the study period.  
 
Statistical Analyses 
Baseline characteristics were described using numbers and percentages (with associated 
95% confidence intervals [CI]) for categorical data, and medians and interquartile ranges 
(IQR) for continuous variables. We quantified the magnitude of variation in patient and 
treatment variables between time periods by calculating the coefficient of variation, CoV 
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(the ratio of the SD to the mean, multiplied by 100), and its confidence interval.18, 19 CoV was 
used because it allows the dispersion of variables with different means to be compared. 
 
The outcome was death in hospital due to any cause. Initially, the unadjusted association of 
four-hour periods with in-hospital mortality was calculated in a univariate logistic regression 
model, and results presented as odds ratios (OR, 95% CI). Subsequently, multilevel logistic 
models (with random intercepts for hospitals) were incrementally adjusted for 1) case mix 
(age, sex) and year of hospitalisation, 2) co-morbidities (CABG surgery, chronic heart failure, 
diabetes mellitus, hypertension, hyperlipidaemia, myocardial infarction, PCI) and smoking 
status, 3) clinical presentation (systolic blood pressure, heart rate, troponin I and T, 
creatinine, cardiac arrest, cardiac enzyme positive, and ST-segment depression), 4) acute 
treatments (ambulance transportation to hospital, thrombolysis, primary PCI, coronary 
angiography performed in hospital, pre-hospital ECG, and any ECG), 5) hospital medications 
taken at time of or pre hospitalization (aspirin, ACE inhibitor/ARB, beta blocker and statin). 
The average annual volume and socioeconomic deprivation level were fitted in the final 
models.  
 
Multiple imputation by chained equations was used to produce 10 imputed data sets to 
minimize bias caused by missing data (Supplementary eTable 3). Pooled estimates and 
accompanying 95% CIs ┘WヴW ｪWﾐWヴ;デWS ;IIﾗヴSｷﾐｪ デﾗ ‘┌Hｷﾐげゲ ヴ┌ﾉWゲく Iﾏヮヴﾗ┗WﾏWﾐデゲ ｷﾐ ﾏﾗSWﾉ 
fit at each stage were determined by minimizing the Akaike and Bayesian information 
criteria ranges across the 10 imputed datasets. Multiply imputed estimates were compared 
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with those from complete case data.  We investigated whether the order of covariates in 
the multilevel model influenced the results by altering the order of covariate blocks entering 
or leaving the multilevel models through forward and backward model selection. The 
likelihood ratio test (LRT) was used to assess the significance of time of hospitalization in 
each model. To assess the association between daytime and night-time hospitalization and 
in-hospital mortality, inverse-probability weighting propensity score analysis was used to 
match the characteristics and treatments for patients admitted at daytime and night-time 
(supplementary eSection 3). To assess the potential of selection bias, an instrumental 
variable analysis was performed to include the hospital rates of guideline-indicated 
treatments as instrumental variables (supplementary eSection 3). Finally, sensitivity analysis 
was performed to investigate whether the time of symptom onset (rather than time of 
hospitalisation), and whether day time defined as 09:00 to 16:59 (rather than 08:00 to 
19:59) altered the results (supplementary eSection 4).  
All tests were 2-sided, and statistical significance was considered p < 0.05. Statistical 







Among 615,035 patients with AMI (median age 70.0 years, IQR 59.0-80.0 years; 406,519 
(66.0%) men), there were 52,777 (8.8%) in-hospital deaths. Patients were co-morbid:  
almost half had a history of hypertension, and nearly a quarter had diabetes, 
hyperlipidaemia or previous myocardial infarction (Table 1). The most frequent time of 
hospitalization was 12:00 to 15:59 for STEMI, with 59,867 (23.8%) STEMI admissions within 
this time interval, and 08:00 to 11:59 for NSTEMI, with 86,583 (23.8%) NSTEMI admissions 
(Table 1). In general, admission systolic blood pressure, heart rate and creatinine did not 
vary over the 24-hour clock (CoV between 0.9 and 2.0, supplementary eTables 1-2).  
 
STEMI 
For STEMI, the proportion of patients with diabetes (range across all time periods 13.5% to 
15.2%), previous PCI (5.1% to 6.0%), previous myocardial infarction (11.9% to 14.1%) and 
current smokers (65.1% to 69.5%) was highest at 00:00-03:59 compared with patients 
hospitalised during other time periods of the day; the greatest variation in co-morbidities 
being for patients with previous CABG surgery (CoV 8.9) (Supplementary eTable 1). For 
STEMI, the use of reperfusion was high and more frequent at night between 00:00-07:59 






For NSTEMI, at night patients more frequently had chronic heart failure (range across all 
time periods 6.7% to 8.8%), diabetes (21.1% to 25.4%), CABG surgery (6.9% to 8.6%) and 
previous myocardial infarction (23.2% to 30.5%), the greatest variation in co-morbidities 
being for patients with previous myocardial infarction (CoV 12.4, supplementary eTable 2). 
For NSTEMI, hospitalization via ambulance demonstrated wide variation, being more 
frequent at night (minimum 57.4% at 16:00 to 19:59, maximum 77.8% at 00:00 to 03:59, 
CoV 11.2). Similarly, electrocardiographic ST-depression (23.9% to 29.6%) was more 
frequent at night. The proportion of NSTEMI with cardiac arrest was highest in the evening 
and lowest during the early hours (minimum 0.9% at 00:00 to 03:59, maximum 1.5% at 
20:00 to 23:59). Coronary angiography performed during the hospital stay was more 
frequent among NSTEMI who presented between 16:00 and 19:59 (41.9%).  
 
STEMI versus NSTEMI 
Overall, the use of an ambulance to attend hospital was high(64.8% to 70.7% for STEMI, 
57.4% to 77.8% for NSTEMI), and varied less over the 24-hour clock for STEMI(CoV 8.8) than 
NSTEMI(CoV 24.7)(supplementary eTables 1-2). An ECG was performed less frequently at 
night for NSTEMI(74.8% to 77.3%), whereas for STEMI it varied little(78.2% to 79.3%). The 
proportion of patients who did not receive aspirin on admission to hospital was stable 






For STEMI, unadjusted in-hospital mortality rates were the highest between 20:00 and 23:59 
(all time periods range 8.4% to 9.9%; OR compared with 00:00 to 03:59 reference 1.13, 95% 
CI 1.07 to 1.20), and for NSTEMI between 12:00 to 15:59 (8.0% to 8.8%; OR compared with 
00:00 to 03:59 reference 1.07, 95% CI 1.03 to 1.12). Unadjusted in-hospital mortality rates 
declined over the study period (for STEMI from 12.2%, 95% CI 11.9% to 12.5% in 2004/5 to 
7.3%, 95% CI 7.1% to 7.6% in 2012/13; for NSTEMI from 12.9%, 95% CI 12.6% to 13.1% in 
2004/5 to 5.8 %, 95% CI 5.6% to 5.9% in 2012/13) as did their variation over the 24-hour 
clock (for STEMI, from CoV 7.2 in 2004/5 to 5.4 in 2012/13; for NSTEMI, from CoV 6.2 in 
2004/2005 to 3.1 in 2012/2013) (Figure 1). 
 
For STEMI, adjustment for demographics, co-morbidities and clinical presentation resulted 
in no association between the time of hospitalization and in-hospital mortality for three of 
the five time periods (Table 2, Figure 2). With further adjustment for the use of acute 
treatments, there was no association between the time of hospitalization with STEMI and 
in-hospital mortality across the 24-hour clock.  For NSTEMI, adjustment for demographics, 
co-morbidities and clinical presentation resulted in no association between the time of 
hospitalization and in-hospital mortality for two of the five time periods (Table 2, Figure 2). 
With further adjustments for the use of acute treatments as well as hospital medications 
taken at time of or pre- hospitalisation, there was no association between the time of 
hospitalization with NSTEMI and in-hospital mortality across the 24-hour clock. For each of 
STEMI and NSTEMI full adjustment for demographics, co-morbidities, clinical presentation, 
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treatments and medications resulted in no significant association between the time of 
presentation to hospital and in-hospital death (STEMI LRT p-value 0.062; NSTEMI LRT p-
value 0.091) (Table 2, supplementary eTables 6-7).  
 
The direction and magnitude of the unadjusted and adjusted estimated for the complete 
case analysis were consistent with the imputed data analysis (Supplementary eTable 4). 
Similarly, the order of covariates entering the model did not influence the final result 
(Supplementary eTable 5).  
 
Propensity score and instrumental variable analysis 
Propensity score analysis showed that for 2004-2013 in-hospital mortality was lower for 
STEMI hospitalised during the day (08:00-19:59, OR: 0.95, 95% CI: 0.93 to 0.97) compared 
with night (20:00-07:59). However, for the period 2008-2013 in-hospital mortality was not 
significantly different between daytime and night-time hospitalization (OR: 0.97, 95% CI: 
0.94 to 1.01) (Supplementary eTable 8). The instrumental variable analysis showed the same 
trend and magnitude of association between in-hospital mortality and time of 
hospitalisation (Supplementary eTable 9). For NSTEMI, both propensity score analysis and 
instrumental variable analysis found no association between time of hospitalisation and in-
hospital mortality for either the whole or the recent period (Supplementary tables 8-9). The 
same trend and magnitude of association was evident in both propensity score and 
instrumental variable analyses when day and night were redefined as 09:00-16:59 and 




A significant association between in-hospital mortality and time of symptom onset or day 
time defined as 09:00 to 16:59 (rather than 08:00 to 19:59) was observed in the period 








In this study of over 600,000 patients hospitalized in England and Wales with AMI, at night 
patients more frequently were co-morbid, and for STEMI had longer symptom-to-
reperfusion times. Although in-hospital mortality varied throughout the 24-hour clock and 
was higher for STEMI, the variation was small, decreased over time, and did not show a 
clear nocturnal peak. We found that adjustments for case mix removed much, but not all of 
the variation in mortality by time of admission, which was non-significant after further 
adjustment for the use of treatments. As such, there is little evidence to support an 
association between time of hospitalization and in-hospital mortality for acute myocardial 
infarction, and variation in in-hospital mortality may be explained by case mix and the use of 
treatments.  
 
The recent literature highlights out-of-hour effects for several medical conditions, yet 
debate arises as to whether this may be due to reduced staffing, infrastructure and delivery 
of healthcare, or a more unwell patient population who present to hospital out of normal 
working hours.1,2,20 Earlier work found that hospitalisation at the weekend with AMI was 
associated with higher mortality and lower use of invasive coronary procedures.11 Our study 
extends this work to time-of-day effects, showing that in the later years of study there was 





Uniform and standardised provision of evidence-based care is associated with improved 
clinical outcomes for AMI.21-24 For patients with NSTEMI, temporal improvements in survival 
were explained by an increase in the uptake of an invasive coronary strategy,15 and for 
STEMI associated with the use of evidence-based pharmacotherapies and primary PCI.25 The 
implementation of a national primary PCI programme has enabled 24/7 availability of 
guideline-recommended treatments in the UK,15,26 although there remains variation across 
Europe.27,28 Over the study period we found a decrease in absolute mortality, also noted by 
others,23,29,30 but also a reduction in the variation in mortality associated with time of 
admission.  Extrapolation of these findings suggests that for common medical emergencies, 
hospital-based population-wide delivery of high quality care is achievable and, if 
implemented, would contribute to temporal reductions and less variation in mortality.  
 
However, we also noticed opportunities where care quality could be enhanced. For STEMI, 
patients had longer symptom-to-reperfusion times at night, and less frequently received 
primary PCI suggesting that there are potentially modifiable delays to the seeking, access 
and provision of care. Equally, there was evidence for variation in coronary angiography 
according to when a patient presented to hospital with NSTEMI に and after adjustment for 
this, treatments and case mix, any variation in in-hospital was removed. Thus, although case 
mix accounts for some mortality variation, more uniform delivery of invasive coronary 




This study has a number of strengths. In the UK, AMI data are collected from all acute 
hospitals, which includes demographic, co-morbidity, treatments and mortality data,14 
thereby allowing a sufficiently detailed time series analysis. Moreover, AMI is an ideal 
medical condition to investigate potential out-of-hour effects に given that it is a medical 
emergency with associated immediate risk of mortality and there are international guideline 
recommended treatments for STEMI and NSTEMI31,32 which, if implemented, reduce 
mortality.15, 30 Although MINAP is a single-health-system prospective observational cohort of 
AMI (designed to be representative of a population), there are limitations that must be 
considered. The study was reliant on accurate data recording. Not all cases of NSTEMI are 
recorded in MINAP,33 and it is possible that there was selection bias in recording of patients 
according to time of hospitalization. We did not have access to more recent MINAP data, 
and due to General Data Protection Regulations were not permitted day of the week data. 
The use of high-sensitivity troponin assays may have contributed to an increased proportion 
of AMI in later years that may not previously have been diagnosed as such.34, 35 However, 
this is unlikely to have had an effect for patients with STEMI in whom the findings were 
concordant with NSTEMI.  In the UK about 60% of patients with out of hospital cardiac 
arrest have a cardiac aetiology,36 and survivorship bias is possible. Nonetheless, this study 
was designed to investigate whether out-of-hours hospital admission (not pre-hospital 
cases) with AMI was associated with an increased mortality. To that effect, we recognise 
that circadian rhythms in platelet aggregation contribute to sudden cardiac death.37 Pre-
hospital delays to seeking help may have varied by time of hospitalization; even so, a 
sensitivity analysis by time of symptom onset found results consistent with the primary 
analysis of time of hospitalisation. We report all-cause rather than cardiovascular-specific 
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mortality, but for in-hospital mortality following AMI this is unlikely to affect the conclusions 
drawn.38 Hospital facility and infrastructure factors have been shown to be significantly 
associated with the nationwide diffusion of primary PCI in the UK. Whilst we accounted for 
hospital level variables within the limitations of the dataset using propensity score analysis 
and instrumental variable analysis, residual confounding may exist including factors such as 
seniority of staff, staffing ratios and access to diagnostics, which are not recorded in MINAP. 
WW ;Iﾆﾐﾗ┘ﾉWSｪW デｴ;デ ゲ┌Iｴ けﾉW┗Wﾉ ヲ Iﾗ┗;ヴｷ;デWゲげ ;ヴW ヮﾗデWﾐデｷ;ﾉﾉ┞ ｷﾏヮortant factors in health 
service delivery and any associated outcomes. Finally, this is an observational study, and as 
such cannot demonstrate causation. 
 
In conclusion, for patients hospitalized in England and Wales with AMI, there is little 
evidence to support an association between time of hospitalization and in-hospital mortality 
for acute myocardial infarction, in particular that of increased mortality out of hours. 
Moreover, any variation in in-hospital mortality associated with time of hospitalization was 
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Figure 1. Crude in-hospital mortality rates by time of admission to hospital for 
STEMI and NSTEMI, stratified by biennial year of hospitalization.  
Footnote: Dots represent in-hospital mortality rates per every 10 minutes of time of 
admission to hospital. Time data are fitted using cubic polynomials with 
trigonometric transformation to the time of hospitalization to ensure that the 
mortality at 00.05 and 23.55 is just ten minutes apart 
 
Figure 2. Unadjusted and multivariable adjusted risk of in-hospital mortality 
according to time period of admission to hospital for STEMI and NSTEMI.  
 
Take-home figure: Adjusted odds ratios for in-hospital mortality by time of 
hospitalisation, showing no significant difference across the six time-intervals of 
the 24-hour clock 
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